Related Experiment Video
Updated: Mar 31, 2026

Author Spotlight: Advancements in Refractive Surgical Correction for Presbyopia and Exploring Postoperative Visual Acuity
Published on: September 20, 2024
Lasik Xtra® Provides Corneal Stability and Improved Outcomes
Rajesh K Rajpal1, Christine B Wisecarver2, Dawn Williams2
1See Clearly Vision Group, 8138 Watson Street, Mclean, VA, USA. rrajpal@seeclearly.com.
A new LASIK Xtra procedure combines LASIK with corneal cross-linking to improve corneal strength and visual outcomes. This review examines the clinical evidence on its safety and efficacy compared to traditional LASIK.
Area of Science:
- Ophthalmology
- Refractive Surgery
- Corneal Surgery
Background:
- Traditional LASIK surgery corrects refractive errors but can sometimes lead to corneal weakening.
- Corneal cross-linking is a procedure to strengthen the cornea.
- LASIK Xtra combines LASIK with corneal cross-linking.
Purpose of the Study:
- To review the clinical evidence on the safety and efficacy of LASIK Xtra.
- To evaluate LASIK Xtra as an alternative to traditional LASIK.
Main Methods:
- Literature review of published clinical studies on LASIK Xtra.
- Analysis of safety and efficacy data.
Main Results:
- The review synthesizes current clinical evidence on LASIK Xtra.
- The procedure aims to enhance corneal strength and visual stability.
- Potential benefits include improved refractive accuracy and reduced need for enhancements.
Conclusions:
- LASIK Xtra presents a promising alternative to traditional LASIK.
- Further evidence is needed to fully establish its long-term safety and efficacy profile.
More Related Videos
05:14Comparison of Agreement and Accuracy using Binocular Wavefront Optometer with Autorefractor and Phoropter
Published on: September 16, 2025
07:29Three Different Protocols of Corneal Collagen Crosslinking in Keratoconus: Conventional, Accelerated and Iontophoresis
Published on: November 12, 2015
Related Concept Videos
Angle Closure Glaucoma: Treatment
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...